- Report
- October 2024
- 198 Pages
Global
From €3518EUR$3,545USD£2,920GBP
€3909EUR$3,939USD£3,244GBP
- Report
- October 2024
- 181 Pages
Global
From €3518EUR$3,545USD£2,920GBP
€3909EUR$3,939USD£3,244GBP
- Report
- May 2024
- 133 Pages
Global
From €6449EUR$6,499USD£5,353GBP
- Report
- July 2024
- 100 Pages
Global
From €2977EUR$3,000USD£2,471GBP
€3721EUR$3,750USD£3,089GBP
- Report
- June 2024
- 200 Pages
Global
From €6311EUR$6,360USD£5,238GBP
€7889EUR$7,950USD£6,548GBP
- Report
- May 2024
- 200 Pages
Global
From €4118EUR$4,150USD£3,418GBP
- Report
- January 2024
- 243 Pages
Global
€4957EUR$4,995USD£4,114GBP
- Report
- August 2024
- 175 Pages
Global
From €4962EUR$5,000USD£4,118GBP
- Report
- February 2024
- 250 Pages
Global
From €4962EUR$5,000USD£4,118GBP
- Report
- February 2024
- 175 Pages
Global
From €4962EUR$5,000USD£4,118GBP
- Report
- February 2024
- 175 Pages
Global
From €4962EUR$5,000USD£4,118GBP
- Report
- December 2024
- 192 Pages
Global
From €4912EUR$4,950USD£4,077GBP
- Report
- December 2024
- 193 Pages
Global
From €4912EUR$4,950USD£4,077GBP
- Report
- May 2024
- 130 Pages
Global
From €6449EUR$6,499USD£5,353GBP
- Report
- May 2024
- 139 Pages
Global
From €6449EUR$6,499USD£5,353GBP
- Report
- August 2024
- 60 Pages
Global
From €1191EUR$1,200USD£988GBP
€1488EUR$1,500USD£1,235GBP
- Report
- June 2024
- 200 Pages
Global
From €6311EUR$6,360USD£5,238GBP
€7889EUR$7,950USD£6,548GBP
- Report
- June 2024
- 200 Pages
Global
From €6311EUR$6,360USD£5,238GBP
€7889EUR$7,950USD£6,548GBP
- Report
- June 2024
- 200 Pages
Global
From €6311EUR$6,360USD£5,238GBP
€7889EUR$7,950USD£6,548GBP
- Report
- June 2024
- 200 Pages
Global
From €6311EUR$6,360USD£5,238GBP
€7889EUR$7,950USD£6,548GBP
The Psoriasis Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat psoriasis, a chronic skin condition. Psoriasis is characterized by red, scaly patches on the skin, and can cause itching, burning, and pain. Psoriasis drugs are designed to reduce inflammation, reduce the rate of skin cell growth, and reduce the severity of symptoms.
The Psoriasis Drugs market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include AbbVie, Amgen, Celgene, Janssen, and Novartis. These companies offer a range of treatments, including topical creams, oral medications, and biologic drugs. Other companies in the market include Sun Pharmaceuticals, Glenmark Pharmaceuticals, and Lupin Pharmaceuticals. Show Less Read more